|
1
|
Bauml JM, Aggarwal C and Cohen RB:
Immunotherapy for head and neck cancer: Where are we now and where
are we going? Ann Transl Med. 7 (Suppl 7):S752019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Twomey JD and Zhang B: Cancer
immunotherapy update: FDA-approved checkpoint inhibitors and
companion diagnostics. AAPS J. 23:392021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Samra B, Tam E, Baseri B and Shapira I:
Checkpoint inhibitors in head and neck cancer: Current knowledge
and perspectives. J Investig Med. 66:1023–1030. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cohen EEW, Bell RB, Bifulco CB, Burtness
B, Gillison ML, Harrington KJ, Le QT, Lee NY, Leidner R, Lewis RL,
et al: The society for immunotherapy of cancer consensus statement
on immunotherapy for the treatment of squamous cell carcinoma of
the head and neck (HNSCC). J Immunother Cancer. 7:1842019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lenouvel D, González-Moles MÁ, Talbaoui A,
Ramos-García P, González-Ruiz L, Ruiz-Ávila I and Gil-Montoya JA:
An update of knowledge on PD-L1 in head and neck cancers:
Physiologic, prognostic and therapeutic perspectives. Oral Dis.
26:511–526. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
De Vicente JC, Rodríguez-Santamarta T,
Rodrigo JP, Blanco-Lorenzo V, Allonca E and García-Pedrero JM:
PD-L1 expression in tumor cells is an independent unfavorable
prognostic factor in oral squamous cell carcinoma. Cancer Epidemiol
Biomarkers Prev. 28:546–554. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Forster MD and Devlin MJ: Immune
checkpoint inhibition in head and neck cancer. Front Oncol.
8:3102018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
McCusker MG, Orkoulas-Razis D and Mehra R:
Potential of pembrolizumab in metastatic or recurrent head and neck
cancer: Evidence to date. Onco Targets Ther. 13:3047–3059. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Unetsubo T, Konouchi H, Yanagi Y, Murakami
J, Fujii M, Matsuzaki H, Hisatomi M, Nagatsuka H and Asaumi JI:
Dynamic contrast-enhanced magnetic resonance imaging for estimating
tumor proliferation and microvessel density of oral squamous cell
carcinomas. Oral Oncol. 45:621–626. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pałasz P, Adamski Ł, Górska-Chrząstek M,
Starzyńska A and Studniarek M: Contemporary diagnostic imaging of
oral squamous cell carcinoma-A review of literature. Pol J Radiol.
82:193–202. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Koh YW, Han JH, Yoon DH, Suh C and Huh J:
PD-L1 expression correlates with VEGF and microvessel density in
patients with uniformly treated classical Hodgkin lymphoma. Ann
Hematol. 96:1883–1890. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Szafarowski T, Sierdzinski J, Szczepanski
MJ, Whiteside TL, Ludwig N and Krzeski A: Microvessel density in
head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol.
275:1845–1851. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brierley JD, Gospodarowicz MK and
Wittekind CH: TNM Classification of Malignant Tumours, 8th Edition.
Oxford, UK; Hoboken, NJ: John Wiley & Sons, Inc.; 2017
|
|
14
|
Takabatake K, Tsujigiwa H, Nakano K, Inada
Y, Qiusheng S, Kawai H, Sukegawa S, Fushimi S and Nagatsuka H:
Geometrical structure of honeycomb TCP to control dental
pulp-derived cell differentiation. Materials (Basel). 13:51552020.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nowak-Sliwinska P, Alitalo K, Allen E,
Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO, van
Beijnum JR, Bender RHF, et al: Consensus guidelines for the use and
interpretation of angiogenesis assays. Angiogenesis. 21:425–532.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Weidner N, Semple JP, Welch WR and Folkman
J: Tumor angiogenesis and metastasis-correlation in invasive breast
carcinoma. N Engl J Med. 324:1–8. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fang L, He Y, Liu Y, Ding H, Tong Y, Hu L,
Wang C, Zhang Y, Zheng X and Huang P: Adjustment of microvessel
area by stromal area to improve survival prediction in non small
cell lung cancer. J Cancer. 10:3397–3406. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Surov A, Meyer HJ, Gawlitza M, Höhn AK,
Boehm A, Kahn T and Stumpp P: Correlations between DCE MRI and
histopathological parameters in head and neck squamous cell
carcinoma. Transl Oncol. 10:17–21. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Surov A, Meyer HJ, Leifels L, Höhn AK,
Richter C and Winter K: Histogram analysis parameters of dynamic
contrast-enhanced magnetic resonance imaging can predict
histopathological findings including proliferation potential,
cellularity, and nucleic areas in head and neck squamous cell
carcinoma. Oncotarget. 9:21070–21077. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jansen JFA, Carlson DL, Lu Y, Stambuk HE,
Moreira AL, Singh B, Patel SG, Kraus DH, Wong RJ, Shaha AR, et al:
Correlation of a priori DCE-MRI and 1H-MRS data with molecular
markers in neck nodal metastases: Initial analysis. Oral Oncol.
48:717–722. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Asaumi J, Yanagi Y, Konouchi H, Hisatomi
M, Matsuzaki H and Kishi K: Application of dynamic
contrast-enhanced MRI to differentiate malignant lymphoma from
squamous cell carcinoma in the head and neck. Oral Oncol.
40:579–584. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yanagi Y, Asaumi JI, Unetsubo T, Ashida M,
Takenobu T, Hisatomi M, Matsuzaki H, Konouchi H, Katase N and
Nagatsuka H: Usefulness of MRI and dynamic contrast-enhanced MRI
for differential diagnosis of simple bone cysts from true cysts in
the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
110:364–369. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hisatomi M, Yanagi Y, Konouchi H,
Matsuzaki H, Takenobu T, Unetsubo T and Asaumi JI: Diagnostic value
of dynamic contrast-enhanced MRI for unilocular cystic-type
ameloblastomas with homogeneously bright high signal intensity on
T2-weighted or STIR MR images. Oral Oncol. 47:147–152. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Matsuzaki H, Hara M, Yanagi Y, Asaumi JI,
Katase N, Unetsubo T, Hisatomi M, Konouchi H, Takenobu T and
Nagatsuka H: Magnetic resonance imaging (MRI) and dynamic MRI
evaluation of extranodal non-Hodgkin lymphoma in oral and
maxillofacial regions. Oral Surg Oral Med Oral Pathol Oral Radiol.
113:126–133. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fujita M, Matsuzaki H, Yanagi Y, Hara M,
Katase N, Hisatomi M, Unetsubo T, Konouchi H, Nagatsuka H and
Asaumi JI: Diagnostic value of MRI for odontogenic tumours.
Dentomaxillofac Radiol. 42:201202652013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schlüter A, Weller P, Kanaan O, Nel I,
Heusgen L, Höing B, Haßkamp P, Zander S, Mandapathil M, Dominas N,
et al: CD31 and VEGF are prognostic biomarkers in early-stage, but
not in late-stage, laryngeal squamous cell carcinoma. BMC Cancer.
18:2722018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tonino P and Abreu C: Microvessel density
is associated with VEGF and α-SMA expression in different regions
of human gastrointestinal carcinomas. Cancers (Basel). 3:3405–3418.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Usuda K, Iwai S, Funasaki A, Sekimura A,
Motono N, Ueda Y, Shimazaki M and Uramoto H: Expression and
prognostic impact of VEGF, CD31 and αSMA in resected primary lung
cancers. Anticancer Res. 38:4057–4063. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
dela Paz NG, Walshe TE, Leach LL,
Saint-Geniez M and D'Amore PA: Role of shear-stress-induced VEGF
expression in endothelial cell survival. J Cell Sci. 125:831–843.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He J, Chen XF, Xu MG and Zhao J:
Relationship of programmed death ligand-1 expression with
clinicopathological features and prognosis in patients with oral
squamous cell carcinoma: A meta-analysis. Arch Oral Biol.
114:1047172020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Meyer HJ, Höhn AK and Surov A:
Associations between histogram analysis parameters derived from
dynamic-contrast enhanced MRI and PD L1-expression in head and neck
squamous cell carcinomas. A preliminary study. Magn Reson Imaging.
72:117–121. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yugawa K, Itoh S, Yoshizumi T, Iseda N,
Tomiyama T, Toshima T, Harada N, Kohashi K, Oda Y and Mori M:
Prognostic impact of tumor microvessels in intrahepatic
cholangiocarcinoma: Association with tumor-infiltrating
lymphocytes. Mod Pathol. 34:798–807. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Franz L, Alessandrini L, Calvanese L,
Crosetta G, Frigo AC and Marioni G: Angiogenesis, programmed death
ligand 1 (PD-L1) and immune microenvironment association in
laryngeal carcinoma. Pathology. May 13–2021.(Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
